| Metric | Current Period | Prior Year Period | YoY |
|---|---|---|---|
| Revenue | ¥247.1B | ¥225.9B | +9.4% |
| Operating Income | ¥35.7B | ¥25.6B | +39.5% |
| Ordinary Income | ¥35.5B | ¥23.4B | +51.6% |
| Net Income | ¥25.1B | ¥15.2B | +64.7% |
| ROE | 1.8% | 1.1% | - |
FY2026 Q1 results delivered strong top-line and profit growth: Revenue ¥247.1B (YoY +¥21.2B +9.4%), Operating Income ¥35.7B (YoY +¥10.1B +39.5%), Ordinary Income ¥35.5B (YoY +¥12.1B +51.6%), Net Income ¥25.1B (YoY +¥9.9B +64.7%). Operating margin improved to 14.4% (up +3.9pt from 10.5% a year earlier) as a substantial decline in SG&A ratio generated operating leverage. Net Income outpaced Operating Income growth, aided by a lower effective tax rate of 29.1% versus 34.8% prior year. Progress against full-year guidance (Revenue ¥940B, Operating Income ¥105B, Ordinary Income ¥110B, Net Income ¥77B) stands at Revenue 26.3%, Operating Income 34.0%, Ordinary Income 32.3%, Net Income 32.6% — notably ahead of the seasonal benchmark (25%) on profitability. The core Writing Instruments and Related Products business drove results with Revenue ¥240.6B (+9.6%) and Operating Income ¥34.9B (+40.2%), lifting its margin to 14.5%. Total assets were ¥1,914.5B (YoY +¥84.5B +4.6%), Net assets ¥1,422.4B (YoY +¥18.1B +1.3%), maintaining a high Equity Ratio of 74.3% (prior year 75.7%).
[Revenue] Revenue rose to ¥247.1B (+9.4%). By segment, the Writing Instruments and Related Products business accounted for ¥240.6B (+9.6%), representing 97.3% of sales; Other businesses totaled ¥6.6B (+2.3%), 2.7% composition. The core segment’s growth appears driven by price revisions taking hold and product mix improvement. Although regional/product breakdowns were not disclosed, the marked improvement in operating margin suggests a shift toward higher-margin product groups. Cost of sales was ¥124.8B (prior ¥107.0B, +16.6%), leading to a gross margin of 49.5% (down -3.1pt from 52.6%), indicating costs rose ahead of sales growth.
[Profitability] Operating Income of ¥35.7B (+39.5%) was driven by improved SG&A efficiency. SG&A fell to ¥86.7B (prior ¥93.3B, -7.1%) in absolute terms, reducing the SG&A ratio to 35.1% (down -6.2pt from 41.3%). The decline in gross margin was absorbed by SG&A compression, resulting in an Operating Margin of 14.4% (prior 10.5%). Non-operating items included interest income ¥0.2B and dividend income ¥0.3B against interest expense ¥0.8B and foreign exchange loss ¥0.4B, yielding a minor non-operating net of -¥0.2B. Ordinary Income ¥35.5B (+51.6%) outpaced Operating Income growth, aided by containment of non-operating expenses. Extraordinary items comprised gain on sale of fixed assets ¥0.01B and loss on disposal ¥0.11B, net -¥0.10B (immaterial). Profit before tax was ¥35.4B (+51.5%) and income taxes were ¥10.3B (effective tax rate 29.1%, prior 34.8%), with the lower tax burden contributing to Net Income ¥25.1B (+64.7%). Net income attributable to owners of parent, after subtracting non-controlling interests ¥0.4B, was ¥24.6B (prior ¥14.6B, +68.8%). In conclusion, the company achieved revenue growth and significant profit expansion.
The Writing Instruments and Related Products business reported Revenue ¥240.6B (+9.6%), Operating Income ¥34.9B (+40.2%), and Operating Margin 14.5% (up +3.2pt from 11.3%). With a sales composition of 97.3% and accounting for 97.8% of consolidated Operating Income, it is the overwhelmingly dominant segment. Growth and margin expansion occurred concurrently, seemingly driven by price revisions, mix improvement, and SG&A control. Other businesses reported Revenue ¥6.6B (+2.3%), Operating Income ¥0.7B (+16.9%), and Operating Margin 10.5% (up +1.4pt from 9.1%); scale is small though margins improved. Consolidated Operating Income of ¥35.7B reconciles after intersegment eliminations.
[Profitability] Operating Margin 14.4% improved +3.9pt from 10.5%, exceeding the industry median of 6.8% by +7.6pt. Net Profit Margin 10.1% improved +3.6pt from 6.5%, exceeding the industry median 5.9% by +4.2pt. Gross Margin 49.5% declined -3.1pt from 52.6%, but large compression in SG&A ratio to 35.1% (prior 41.3%) unlocked operating leverage. ROE (annualized on a quarterly basis) is 7.2% (annualized Net Income ¥100.4B ÷ beginning equity ¥1,404.3B); while historical series are not disclosed, improved SG&A efficiency and higher Net Profit Margin suggest upward ROE trend.
[Cash Quality] Days Sales Outstanding (DSO) measures 297 days ((Accounts receivable ¥201.0B - Allowance ¥4.9B) ÷ annualized Revenue ¥988.4B × 365). Inventory turnover days are 111 days (Inventory ¥302.4B ÷ annualized Cost of Sales ¥499.2B × 365). Both indicate extension versus prior year, signaling deteriorating working capital efficiency and potential collection/inventory risks. Operating Cash Flow (OCF) data were not disclosed; however, attention is warranted to potential lag in cash collection relative to profit growth.
[Investment Efficiency] Total Asset Turnover is annualized 0.52x (annualized Revenue ¥988.4B ÷ Total Assets ¥1,914.5B), typical for an asset-intensive business. Goodwill ¥56.8B is 4.0% of equity; intangible assets ¥125.0B are 6.5% of total assets — limited, implying modest balance-sheet risk from M&A.
[Financial Soundness] Equity Ratio remains high at 74.3% (prior 75.7%). D/E ratio is conservative at 0.13x (interest-bearing debt ¥191.7B ÷ Net assets ¥1,422.4B). Liquidity is robust: Current Ratio 645% (Current assets ¥989.5B ÷ Current liabilities ¥153.4B) and Quick Ratio 448% ((Cash and deposits ¥428.2B + Accounts receivable ¥201.0B) ÷ Current liabilities ¥153.4B). Short-term funding risk is negligible. Interest coverage is 45.1x (Operating Income ¥35.7B ÷ Interest expense ¥0.8B), indicating limited interest burden. Long-term borrowings increased to ¥177.4B from ¥131.7B (+34.7%), but cash on hand ¥428.2B substantially exceeds this, preserving a net cash position.
Although detailed OCF statement data were not disclosed, inference from P&L and balance sheet movements indicates that while Operating Income increased by ¥35.7B, Inventory ¥302.4B (prior ¥307.5B, -1.7%) and Accounts receivable ¥201.0B (prior ¥203.3B, -1.1%) only declined slightly; working capital compression has not kept pace with Revenue growth of +9.4%. Bonus reserves rose to ¥12.9B (prior ¥6.6B, +96.2%), reflecting increased performance-linked compensation accruals. Accrued income taxes ¥12.8B (prior ¥9.0B, +41.3%) reflect higher profits. Increase in long-term borrowings ¥45.7B suggests funding for growth investments or strategic working capital, but specific uses are undisclosed. Investment securities ¥331.7B (prior ¥320.2B, +3.6%) carry unrealized gains but are subject to market volatility. Cash and deposits increased to ¥428.2B (prior ¥370.7B, +¥57.5B), suggesting cash accumulation from earnings and debt funding. Free Cash Flow (OCF - Investing CF) was not disclosed, but given profit growth and increased cash balances, FCF is inferred to be broadly positive.
Ordinary Income ¥35.5B includes non-operating income of ¥2.1B (non-operating income ratio 0.8%), indicating the principal earnings driver is core operations. Non-operating income breakdown: interest income ¥0.2B, dividend income ¥0.3B, other ¥0.6B — all relatively routine and stable. Non-operating expenses ¥2.2B include interest expense ¥0.8B and foreign exchange loss ¥0.4B; volatile but limited in scale. Extraordinary items are net -¥0.10B (immaterial), so one-off contributions are negligible. The gap between Ordinary Income ¥35.5B and Net Income ¥25.1B (~71%) is primarily due to effective tax rate 29.1% and non-controlling interests ¥0.4B; qualitative concerns are limited. Comprehensive Income ¥33.6B (owners of parent ¥33.5B) exceeds Net Income by ¥8.5B; Other Comprehensive Income breakdown: Foreign currency translation adjustments ¥1.5B, Net change in valuation of securities ¥7.6B, Remeasurements of defined benefit plans -¥0.6B. Unrealized gains on securities raised Comprehensive Income, providing cushions but exposing reversal risk if markets turn. From an accruals perspective, the slowdown in receivables and inventory turnover signals a potential quality concern: prolonged inventory could pressure gross margin via markdowns/write-downs, and slower receivable collection could necessitate higher allowances.
Full-year guidance: Revenue ¥940B (+4.7%), Operating Income ¥105B (+8.3%), Ordinary Income ¥110B (+9.7%), Net Income ¥77B. Q1 progress against guidance: Revenue 26.3%, Operating Income 34.0%, Ordinary Income 32.3%, Net Income 32.6% (annualized EPS 182.2 yen vs. Q1 actual 45.56 yen). Assuming standard seasonality at 25% for Q1, Operating Income is ahead by +9.0pt, Ordinary Income +7.3pt, Net Income +7.6pt. SG&A ratio improvement is the primary driver; if momentum persists, upside to full-year guidance is plausible. However, if Q1 absolute SG&A decline (prior ¥93.3B → ¥86.7B) reflects timing shifts in advertising/promotion or temporary cost suppression, a rebound in H2 could erode margin gains. Inventory and receivable turnover deterioration could also trigger margin pressure through markdowns or intensified promotions. The company has not revised guidance and maintains current plan, but Q1 profit progress materially exceeding plan suggests conservative budgeting or substantial cost control. H2 demand conditions, SG&A levels, and working capital trends will be key to full-year outcomes.
Annual dividend forecast is ¥27.5 per share (interim ¥27.5, year-end ¥27.5), comprising a regular dividend ¥25.5, special dividend ¥1, and 140th anniversary commemorative dividend ¥1. Prior fiscal year dividend was ¥26 (including special ¥1); excluding special dividends, the regular dividend remains ¥25.5 → ¥25.5, with commemorative ¥1 adding an apparent +¥1.5 increase. Based on full-year Net Income forecast ¥77B, shares outstanding 60,042k, treasury stock 5,952k, and shares at fiscal year-end 54,090k, total annual dividend payout is approximately ¥1,490M, yielding a Payout Ratio of 19.3% (Annual DPS ¥27.5 ÷ EPS forecast ¥142.35) — very conservative. With cash on hand ¥428.2B, significant Operating Income increase, and Interest Coverage 45.1x, financial capacity to sustain dividends appears ample. Excluding special/commemorative items, the ordinary dividend is effectively unchanged; there is ample room for dividend increases tied to future profit growth. No share buyback has been disclosed; Total Return Ratio equals the Payout Ratio. Payout Ratio 19.3% is low within the industry, leaving scope to raise shareholder returns while balancing growth investments and financial health.
Working capital efficiency deterioration: DSO 297 days and inventory days 111 indicate lengthening. Cash conversion may lag revenue growth. Prolonged inventory could lead to markdowns/write-downs and compress gross margin, impairing OCF. Elevated receivables increase credit risk and could necessitate higher allowance for doubtful accounts or incur uncollectible receivables.
Sustainability of SG&A control: Q1 SG&A ratio improved to 35.1% (prior 41.3%), boosting Operating Margin, and absolute SG&A fell from ¥93.3B to ¥86.7B (-7.1%). If this reduction stems from timing shifts in advertising/promotion or temporary cost deferral, H2 rebound could reverse margin gains. High inventory/receivables could force intensified promotions or discounts to clear inventory, pressuring both SG&A and gross margin.
Concentration in core segment: The Writing Instruments and Related Products segment represents 97.3% of Revenue and 97.8% of Operating Income, implying limited portfolio diversification. Demand shocks to this segment (e.g., structural decline due to digitalization, intensified competition, shortened product life cycles) directly impact consolidated performance. Other businesses are small and unlikely to offset a slowdown. Geographic diversification is unclear; dependency on specific markets could amplify FX or local regulatory risks.
Profitability & Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Margin | 14.4% | 6.8% (2.9%–9.0%) | +7.6pt |
| Net Profit Margin | 10.1% | 5.9% (3.3%–7.7%) | +4.2pt |
Both Operating and Net margins materially exceed industry medians, placing the company among the more profitable manufacturers.
Growth & Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | 9.4% | 13.2% (2.5%–28.5%) | -3.8pt |
Revenue growth lags the industry median, reflecting a mature business base; high profitability partially offsets the lower growth.
※ Source: Company compilation
Improvement to Operating Margin 14.4% and profit progress ahead of full-year plan reflect successful SG&A efficiency. Operating Income progress of 34.0% (vs. seasonal norm 25%) is +9.0pt; if sustained, upside to FY guidance (Revenue ¥940B / Operating Income ¥105B) is possible. Critical to determine whether the absolute SG&A reduction is temporary (timing) or structural — H2 SG&A trends and gross margin trajectory will determine full-year outcome.
Working capital deterioration signals (DSO 297 days, Inventory days 111) point to potential risks in cash conversion. Protracted inventory build-up could pressure gross margin via markdowns/write-downs, while sustained high receivables raise credit risk and could impair OCF. Disclosure of working capital trends and OCF from Q2 onward will be important to assess earnings quality.
With Payout Ratio 19.3%, cash ¥428.2B, and Equity Ratio 74.3%, financial capacity is strong and dividend sustainability is not a concern. Ordinary dividend is effectively unchanged excluding special and commemorative items, and there is room for future dividend increases if earnings grow. Long-term borrowings increased +34.7% YoY to ¥177.4B; realization of growth investment uses and returns will be a precondition for expanding shareholder returns.
This report is an AI-generated earnings analysis document produced by analyzing XBRL financial statement data. It does not constitute a recommendation to invest in any specific security. Industry benchmarks are reference data compiled by the firm based on public financial statements. Investment decisions are your responsibility; consult a professional advisor as appropriate.